| Literature DB >> 26402912 |
Ping Sun1, Jiangbo Du2, Xun Zhu3, Chuanli Ren4, Lan Xie5, Ningbin Dai2, Yayun Gu2, Caiwang Yan3, Juncheng Dai2, Hongxia Ma3, Yue Jiang3, Jiaping Chen2, Zhibin Hu2, Hongbing Shen2, Haorong Wu6, Guangfu Jin2.
Abstract
NBN plays a crucial role in carcinogenesis as a core component for both homologous recombination (HR) and non-homologous end-joining (NHEJ) DNA double-strand breaks (DSBs) repair pathways. Genetic variants in the NBN gene have been associated with multiple cancers risk, suggesting pleiotropic effect on cancer. We hypothesized that genetic variants in the NBN gene may modify the risk of gastric cancer. To test this hypothesis, we evaluated the association between four potentially functional single nucleotide polymorphisms in NBN and gastric cancer risk in a case-control study of 1,140 gastric cancer cases and 1,547 controls in a Chinese population. We found that the A allele of rs10464867 (G>A) was significantly associated with a decreased risk of gastric cancer (odds ratio [OR] = 0.81, 95% confidence interval [95% CI] = 0.71-0.94; P = 4.71×10-3). Furthermore, the association between A allele of rs10464867 and decreased risk of gastric cancer was more significantly in elder individuals (per-allele OR = 0.72[0.59-0.88], P = 1.07×10-3), and male individuals (per-allele OR = 0.73[0.62-0.87], P = 3.68×10-4). We further conducted a haplotype analysis and identified that the NBN Ars10464867Grs14448Grs1063053 haplotype conferred stronger protective effect on gastric cancer (OR = 0.76[0.65-0.89], P = 6.39×10-4). In summary, these findings indicate that genetic variants at NBN gene may contribute to gastric cancer susceptibility and may further advance our understanding of NBN gene in cancer development.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26402912 PMCID: PMC4581712 DOI: 10.1371/journal.pone.0139059
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Selected characteristics between gastric cancer cases and controls.
| Variables | Case (n = 1,140) | Control (n = 1,547) |
|
|---|---|---|---|
| N (%) | N (%) | ||
| Age | 60.99 ± 10.54 | 60.68 ± 9.21 | 0.412 |
| Gender | |||
| Male | 862 (75.61) | 1153 (74.53) | 0.522 |
| Female | 278 (24.39) | 394 (25.47) | |
| Smoking status | |||
| Never | 595 (52.19) | 812 (52.49) | 0.879 |
| Ever | 545 (47.81) | 735 (47.51) | |
| Drinking status | |||
| Never | 679 (59.56) | 954 (61.67) | 0.269 |
| Ever | 461 (40.44) | 593 (38.33) | |
| Tumor site | |||
| Cardia | 559 (49.04) | ||
| Non-cardia | 581 (50.96) |
a T test was used for age and χ2 test was used for other binary variables.
Association results of four SNPs in NBN with gastric cancer risk.
| SNP | Case | Control | OR (95%CI) |
|
|---|---|---|---|---|
| N (%) | N (%) | |||
| rs10464867 | n = 1139 | n = 1547 | ||
| GG | 806(70.76) | 1029(66.52) | 1.00 | |
| GA | 306(26.87) | 453(29.28) | 0.87(0.73–1.03) | 0.102 |
| AA | 27(2.37) | 65(4.20) | 0.53(0.33–0.84) | 6.35×10−3 |
| GA ± AA | 333(29.24) | 518(33.48) | 0.82(0.70–0.97) | 0.022 |
| A allele | 0.81(0.71–0.94) | 4.71×10−3 | ||
| rs14448 | n = 1136 | n = 1543 | ||
| AA | 687(60.48) | 888(57.55) | 1.00 | |
| AG | 387(34.07) | 549(35.58) | 0.91(0.78–1.08) | 0.284 |
| GG | 62(5.46) | 106(6.87) | 0.76(0.54–1.05) | 0.096 |
| AG ± GG | 449(39.52) | 655(42.45) | 0.96(0.91–1.01) | 0.138 |
| G allele | 0.89(0.79–1.01) | 0.074 | ||
| rs1063045 | n = 1139 | n = 1546 | ||
| GG | 378(33.19) | 517(33.44) | 1.00 | |
| GA | 590(51.80) | 739(47.80) | 1.10(0.93–1.31) | 0.276 |
| AA | 171(15.01) | 290(18.76) | 0.81(0.64–1.02) | 0.070 |
| GA ± AA | 761(66.81) | 1029(66.56) | 1.01(0.95–1.06) | 0.839 |
| A allele | 0.93(0.83–1.04) | 0.207 | ||
| rs1063053 | n = 1137 | n = 1546 | ||
| GG | 430(37.82) | 584(37.77) | 1.00 | |
| GA | 552(48.55) | 710(45.92) | 1.06(0.90–1.25) | 0.493 |
| AA | 155(13.63) | 252(16.30) | 0.84(0.66–1.06) | 0.134 |
| GA ± AA | 707(62.18) | 962(62.23) | 1.00(0.95–1.05) | 0.990 |
| A allele | 0.95(0.85–1.06) | 0.323 |
a Derived from logistic regression with an adjustment for age, sex, smoking and drinking status.
Stratified analysis of associations between rs10464867, rs14448, rs1063053, rs1063045 and gastric cancer risk.
| Variables | rs10464867 (G > A) | rs14448 (A > G) | rs1063053 (G > A) | rs1063045 (G > A) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95%CI) |
|
| OR (95%CI) |
|
| OR (95%CI) |
|
| OR (95%CI) |
|
| |
| Age (years) | ||||||||||||
| < 60 | 0.91(0.73–1.13) | 0.386 | 0.121 | 0.93(0.77–1.13) | 0.482 | 0.438 | 0.90(0.76–1.07) | 0.255 | 0.467 | 0.88(0.74–1.05) | 0.172 | 0.405 |
| ≥ 60 | 0.72(0.59–0.88) | 1.07×10−3 | 0.84(0.71–1.00) | 0.049 | 0.98(0.84–1.14) | 0.780 | 0.97(0.84–1.13) | 0.712 | ||||
| Gender | ||||||||||||
| Male | 0.73(0.62–0.87) | 3.68×10−4 | 0.040 | 0.81(0.70–0.94) | 5.89×10−3 | 0.041 | 0.91(0.80–1.03) | 0.142 | 0.290 | 0.88(0.77–1.00) | 0.048 | 0.067 |
| Femal | 1.05(0.78–1.43) | 0.744 | 1.12(0.85–1.47) | 0.420 | 1.06(0.82–1.36) | 0.662 | 1.15(0.89–1.48) | 0.292 | ||||
| Smoking status | ||||||||||||
| Never | 0.77(0.63–0.94) | 0.011 | 0.458 | 0.85(0.72–1.01) | 0.069 | 0.547 | 1.05(0.90–1.23) | 0.514 | 0.036 | 1.04(0.89–1.22) | 0.589 | 0.023 |
| Ever | 0.86(0.70–1.07) | 0.172 | 0.92(0.76–1.12) | 0.403 | 0.82(0.69–0.97) | 0.019 | 0.80(0.68–0.94) | 8.22×10−3 | ||||
| Drinking status | ||||||||||||
| Never | 0.80(0.67–0.97) | 0.021 | 0.742 | 0.89(0.75–1.04) | 0.150 | 1.000 | 0.96(0.83–1.11) | 0.620 | 0.582 | 0.92(0.79–1.06) | 0.239 | 1.000 |
| Ever | 0.84(0.67–1.05) | 0.124 | 0.89(0.73–1.10) | 0.284 | 0.90(0.75–1.07) | 0.223 | 0.92(0.77–1.10) | 0.354 | ||||
| Tumor site | ||||||||||||
| Cardia | 0.85(0.71–1.02) | 0.075 | 0.447 | 0.95(0.81–1.11) | 0.524 | 0.243 | 0.97(0.84–1.12) | 0.675 | 0.529 | 0.99(0.86–1.14) | 0.867 | 0.198 |
| Non-cardia | 0.77(0.65–0.93) | 6.10×10−3 | 0.83(0.70–0.97) | 0.022 | 0.91(0.79–1.04) | 0.166 | 0.87(0.76–1.00) | 0.052 | ||||
a Derived from additive model using logistic regression analysis with an adjustment for age, sex, smoking and drinking status.
b P for heterogeneity test based on χ2-based Q test.
Association analysis between haplotypes of and gastric cancer susceptibility.
| Haplotype | Case (N%) | Control (N%) | OR(95% CI) |
|
|---|---|---|---|---|
| GAG | 39.78 | 36.10 | ||
| GAA | 37.81 | 39.24 | 0.88(0.77–0.99) | 0.034 |
| AGG | 15.83 | 18.84 | 0.76(0.65–0.89) | 6.39×10−4 |
| GGG | 6.58 | 5.82 | 1.02(0.81–1.29) | 0.843 |
a SNP order: rs10464867, rs14448, and rs1063053.
b Derived from logistic regression with an adjustment for age, sex, smoking and drinking status.